Autoantibody screening in Guillain–Barré syndrome

Autoantibody screening in Guillain–Barré syndrome

Abstract Background Guillain–Barré syndrome (GBS) is an acute inflammatory neuropathy with a heterogeneous presentation. Although some evidences support the role of autoantibodies in its pathogenesis, the target antigens remain unknown in a substantial proportion of GBS patients. The objective of th...

Full description

Bibliographic Details
Main Authors: Cinta Lleixà, Lorena Martín-Aguilar, Elba Pascual-Goñi, Teresa Franco, Marta Caballero, Noemí de Luna, Eduard Gallardo, Xavier Suárez-Calvet, Laura Martínez-Martínez, Jordi Diaz-Manera, Ricard Rojas-García, Elena Cortés-Vicente, Joana Turón, Carlos Casasnovas, Christian Homedes, Gerardo Gutiérrez-Gutiérrez, María Concepción Jimeno-Montero, José Berciano, Maria José Sedano-Tous, Tania García-Sobrino, Julio Pardo-Fernández, Celedonio Márquez-Infante, Iñigo Rojas-Marcos, Ivonne Jericó-Pascual, Eugenia Martínez-Hernández, Germán Morís de la Tassa, Cristina Domínguez-González, Cándido Juárez, Isabel Illa, Luis Querol
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Journal of Neuroinflammation
Subjects:
Guillain–Barré syndrome (GBS)
Autoantibodies
Anti-ganglioside
Neurons
Prognosis
Online Access:https://doi.org/10.1186/s12974-021-02301-0

Internet

https://doi.org/10.1186/s12974-021-02301-0

Similar Items